Merus BV Ownership
| MRUS Stock | USD 40.40 0.52 1.27% |
Shares in Circulation | First Issued 2014-03-31 | Previous Quarter 64.2 M | Current Value 69 M | Avarage Shares Outstanding 31 M | Quarterly Volatility 17.6 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merus BV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. Merus Stock Ownership Analysis
About 98.0% of the company shares are owned by institutional investors. The book value of Merus BV was now reported as 8.62. The company recorded a loss per share of 4.16. Merus BV had not issued any dividends in recent years. Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. The company was incorporated in 2003 and is headquartered in Utrecht, the Netherlands. Merus NV is traded on NASDAQ Exchange in the United States. To find out more about Merus BV contact Sven MD at 31 30 253 8800 or learn more at https://www.merus.nl.Merus Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Merus BV is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Merus BV backward and forwards among themselves. Merus BV's institutional investor refers to the entity that pools money to purchase Merus BV's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Paradigm Biocapital Advisors Lp | 2024-12-31 | 1.7 M | Blackrock Inc | 2024-12-31 | 1.6 M | Westfield Capital Management Company, L.p. | 2025-03-31 | 1.5 M | Driehaus Capital Management Llc | 2024-12-31 | 1.3 M | Woodline Partners Lp | 2024-12-31 | 1.2 M | T. Rowe Price Associates, Inc. | 2024-12-31 | 1.1 M | Ubs Group Ag | 2024-12-31 | 1.1 M | Federated Hermes Inc | 2025-03-31 | 1 M | Pictet Asset Manangement Sa | 2025-03-31 | 1 M | Fmr Inc | 2024-12-31 | 6.9 M | Rtw Investments, Llc | 2024-12-31 | 4.2 M |
Merus BV Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Merus BV insiders, such as employees or executives, is commonly permitted as long as it does not rely on Merus BV's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Merus BV insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Merus BV Outstanding Bonds
Merus BV issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Merus BV uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Merus bonds can be classified according to their maturity, which is the date when Merus BV has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Merus BV Corporate Filings
| 12th of May 2025 Other Reports | ViewVerify | |
10Q | 7th of May 2025 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
| 24th of April 2025 Other Reports | ViewVerify | |
F4 | 21st of April 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Merus Stock Analysis
When running Merus BV's price analysis, check to measure Merus BV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merus BV is operating at the current time. Most of Merus BV's value examination focuses on studying past and present price action to predict the probability of Merus BV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merus BV's price. Additionally, you may evaluate how the addition of Merus BV to your portfolios can decrease your overall portfolio volatility.